Maybe Narachi is a big co boy and needs to go back to a big co with lots of staff and resources. He sure hasn't done a good job in smal companies and has destroyed AMAG, OREX and a little private company REN. You are so right about all of the connectivity. Narachi thought AMAG and OREX were lay ups and did cut corners. It will take 4-5 years to enroll the CV study and to report out the results. And the mess at AMAG with the premium price and lack of acknowledgement that a premium price in a generic market is a sad story. The commercial world has changed since Narachi was at Amgen and he is not keeping up.